<DOC>
	<DOCNO>NCT01901809</DOCNO>
	<brief_summary>Heart Failure preserve Ejection Fraction ( HFPEF ) account 40-50 % heart failure patient frequency hospital admission acute decompensation short long term mortality similar patient heart failure reduce ejection fraction ( HFREF ) . Patients HFPEF often preload dependent despite admission hospital acute decompensated heart failure ( ADHF ) , typically difficult diurese due development acute kidney injury . No study perform evaluate treatment strategy patient . We hypothesize change method diuresis and/or addition low-dose dopamine treatment ADHF patient HFPEF reduce renal injury , result short length stay , decrease hospital readmission ensue year . This trial randomize patient either bolus continuous infusion furosemide either dopamine dopamine . The primary endpoint renal function 72 hour measure change GFR . Secondary endpoint readmission , functional capacity , quality life , amount diuresis also collect .</brief_summary>
	<brief_title>Diuretics Dopamine Heart Failure With Preserved Ejection Fraction</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Heart Failure , Diastolic</mesh_term>
	<mesh_term>Furosemide</mesh_term>
	<mesh_term>Diuretics</mesh_term>
	<mesh_term>Dopamine</mesh_term>
	<mesh_term>Dopamine Agents</mesh_term>
	<criteria>1 . Admission Johns Hopkins Hospital acute decompensated heart failure . 2 . Patient ≥18 year age 3 . Estimated GFR &gt; 15 milliliters/min/1.73m2 determine MDRD equation 4 . Willingness provide informed consent 5 . Known ejection fraction noninvasive test &gt; 50 % within 12 month admission hospital interval myocardial infarction since inclusion transthoracic echo , history , ECG . 6 . Negative pregnancy test female child bear potential 7 . Willingness primary attend physician patient participate . 1 . Systolic BP &lt; 90 mmHg admission 2 . Hemoglobin ( Hgb ) &lt; 8 g/dl 3 . Known allergy intolerance furosemide low dose dopamine . 4 . Hemodynamically significant arrhythmia include ventricular tachycardia defibrillator shock within 4 week 5 . Acute coronary syndrome within 4 week 6 . Cardiac diagnosis addition HFpEF : . Active myocarditis ii . Hypertrophic obstructive cardiomyopathy iii . Severe valvular disease iv . Restrictive constrictive cardiomyopathy , include know amyloidosis , sarcoidosis , hemachromatosis v. Complex congenital heart disease vi . Constrictive pericarditis vii . Severe pulmonary hypertension ( RVSP ≥ 60 ) , secondary HFpEF 7 . Noncardiac pulmonary edema 8 . Clinical evidence digoxin toxicity 9 . Received IV vasoactive treatment ultrafiltration therapy heart failure since initial presentation 10 . Anticipated need IV vasoactive treatment ultrafiltration heart failure hospitalization 11 . History temporary permanent renal replacement therapy ultrafiltration 12 . History renal artery stenosis &gt; 50 % 13 . Need mechanical hemodynamic support 14 . Sepsis 15 . Terminal illness ( HF ) expect survival less 1 year 16 . Previous adverse reaction study drug 17 . Use IV iodinated contrast material/dye last 72 hour plan hospitalization 18 . Enrollment plan enrollment another randomize clinical trial hospitalization 19 . Inability comply plan study procedure 20 . Pregnancy nursing mother</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Heart failure , diastolic</keyword>
	<keyword>HFpEF</keyword>
	<keyword>Diuretics</keyword>
	<keyword>Dopamine</keyword>
</DOC>